# Cryoballoon Isolation of Superior Vena Cava in Paroxysmal Atrial Fibrillation

Study · id `cardio:ct-nct05081310` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05081310](<https://clinicaltrials.gov/study/NCT05081310>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05081310

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

## Technical summary

Registry record NCT05081310. Randomized; no masking; primary purpose treatment. Start 2021-06-01 (actual); primary completion 2024-07-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 100 participants (planned count; ClinicalTrials.gov record NCT05081310, source copy `cardio:ctgov-nct05081310-2023-11-22`, retrieved 2026-10-26)
- Started: 2021-06-01 (actual) (ClinicalTrials.gov record NCT05081310, source copy `cardio:ctgov-nct05081310-2023-11-22`, retrieved 2026-10-26)
- Primary completion: 2024-07-30 (anticipated) (ClinicalTrials.gov record NCT05081310, source copy `cardio:ctgov-nct05081310-2023-11-22`, retrieved 2026-10-26)
- Completion: 2024-07-30 (anticipated) (ClinicalTrials.gov record NCT05081310, source copy `cardio:ctgov-nct05081310-2023-11-22`, retrieved 2026-10-26)
- Countries: Croatia (ClinicalTrials.gov record NCT05081310, source copy `cardio:ctgov-nct05081310-2023-11-22`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05081310-2023-11-22`, retrieved 2026-10-26)

## The registry's words

- Brief title: Cryoballoon Isolation of Superior Vena Cava in Paroxysmal Atrial Fibrillation
- Acronym: CISPAF
- Condition: Atrial Fibrillation
- Intervention (Device): superior vena cava isolation
- Intervention (Device): pulmonary vein isolation
- Lead sponsor: University of Zagreb
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as the lead sponsor: University of Zagreb (`cardio:org-university-of-zagreb`)

## Provenance

Content hash: 189a038417e32199f79f8a17f880cfd69b33be5e74fd422dbadf339f65db2f89
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
